Efficacy and safety of elbasvir/ grazoprevir in women infected with hepatitis C virus genotype 1 or 4 and co-administered oral contraceptives or hormone replacement therapy Dore, G., Hezode, C., Kwo, P., Sperl, J., Hwang, P., Long, J., Talwani, R., Robertson, M., Haber, B. WILEY. 2018: 56–57

View details for Web of Science ID 000435101000092